These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20203149)

  • 1. Antiviral immune response in patients with multiple sclerosis and healthy siblings.
    Comabella M; Montalban X; Horga A; Messmer B; Kakalacheva K; Strowig T; Caballero E; Münz C; Lünemann J
    Mult Scler; 2010 Mar; 16(3):355-8. PubMed ID: 20203149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins.
    Ristori G; Mechelli R; Anderson J; Mengoni F; Sauzullo I; Annibali V; Cannoni S; Aloisi F; James JA; Salvetti M
    Mult Scler; 2010 Dec; 16(12):1527-8. PubMed ID: 20798134
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.
    Lünemann JD; Tintoré M; Messmer B; Strowig T; Rovira A; Perkal H; Caballero E; Münz C; Montalban X; Comabella M
    Ann Neurol; 2010 Feb; 67(2):159-69. PubMed ID: 20225269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
    Najafipoor A; Roghanian R; Zarkesh-Esfahani SH; Bouzari M; Etemadifar M
    Cell Immunol; 2015 Mar; 294(1):9-12. PubMed ID: 25666504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of viral antibodies in Iranian multiple sclerosis patients.
    Khaki M; Ghazavi A; Ghasami K; Rafiei M; Payani MA; Ghaznavi-Rad E; Mosayebi G
    Neurosciences (Riyadh); 2011 Jul; 16(3):224-8. PubMed ID: 21677611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
    Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
    J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between anti-EBNA-1 IgG and multiple sclerosis clinical disease activity.
    Bahreini SA; Zahednasab H; Saadatnia M; Jabalameli MR
    Eur J Neurol; 2010 Oct; 17(10):e95; author reply e96. PubMed ID: 20636367
    [No Abstract]   [Full Text] [Related]  

  • 10. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
    Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
    Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
    Jafari N; van Nierop GP; Verjans GM; Osterhaus AD; Middeldorp JM; Hintzen RQ
    J Clin Virol; 2010 Sep; 49(1):26-31. PubMed ID: 20638898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway.
    Myhr KM; Riise T; Barrett-Connor E; Myrmel H; Vedeler C; Grønning M; Kalvenes MB; Nyland H
    J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):539-42. PubMed ID: 9576551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus infection: a smoking gun for multiple sclerosis?
    Lucas RM; Taylor BV
    Neurology; 2012 Sep; 79(13):1310-1. PubMed ID: 22933742
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis.
    Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
    Neurology; 2012 Sep; 79(13):1363-8. PubMed ID: 22933744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.
    Sundström P; Juto P; Wadell G; Hallmans G; Svenningsson A; Nyström L; Dillner J; Forsgren L
    Neurology; 2004 Jun; 62(12):2277-82. PubMed ID: 15210894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-barr virus and multiple sclerosis risk in the finnish maternity cohort.
    Munger KL; Hongell K; Cortese M; Åivo J; Soilu-Hänninen M; Surcel HM; Ascherio A
    Ann Neurol; 2019 Sep; 86(3):436-442. PubMed ID: 31226219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy.
    Comabella M; Kakalacheva K; Río J; Münz C; Montalban X; Lünemann JD
    Mult Scler; 2012 May; 18(5):605-9. PubMed ID: 22020417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
    Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
    J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: the elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
    Ruprecht K; Wunderlich B; Gieß R; Meyer P; Loebel M; Lenz K; Hofmann J; Rosche B; Wengert O; Paul F; Reimer U; Scheibenbogen C
    J Neuroimmunol; 2014 Jul; 272(1-2):56-61. PubMed ID: 24798244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.